Citigroup’s MDxHealth MDXH Stock Holding History

Citigroup’s Portfolio MDXH Stock Details MDXH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-18,945	Closed	-$43.6K	–	6053
2026 Q1	$43.6K	Sell	18,945 -6,004	-24%	-$20.4K	﹤0.01%	4575
2025 Q4	$89.1K	Buy	+24,949	New	+$98.6K	﹤0.01%	4367

Other funds holding MDXH

Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return

MVM Partners Boston, Massachusetts $1.91M AUM 81.42% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Citigroup's MDXH Position: Q2 2026 in Review

Citigroup sold out of MDxHealth (MDXH) in Q2 2026, closing a stake of 18,945 shares — an estimated $43.6K sold.

Citigroup first reported a position in MDXH in Q4 2025 and held it in 2 quarters. The position peaked at $89.1K in Q4 2025. 26 funds tracked by Wall St. Rank hold MDXH as of Q2 2026.

Citigroup reported no remaining MDxHealth position as of Q2 2026 after selling out during the quarter.
Citigroup sold 18,945 MDxHealth shares in Q2 2026, an estimated $43.6K.
Citigroup first reported a position in MDxHealth in Q4 2025 and held it in 2 quarters.
Citigroup's MDxHealth position peaked at $89.1K in Q4 2025.
26 funds tracked by Wall St. Rank held MDxHealth as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.